platinum-based therapyhyperthermic intraperitoneal chemotherapyovarian cancerBevacizumabTrastuzumab deruxtecanadavosertibmirvetuximab soravtansineHER2-expressing diseasePROC
…s in approximately 70% of cases. In platinum-sensitive relapse, platinum-based therapy remains the backbone of treatment, with optional integration of…